Should I buy Celsius Holdings stock in 2025? Expert Advice for UAE Investors

What is Celsius Holdings?

How much is the Celsius Holdings stock?

The price of Celsius Holdings stock is rising this week. As of now, CELH is trading at $36.34, showing a positive change of +$1.41 (+4.04%) over the past 24 hours and up 2.48% for the week.

A beta of 1.63 suggests that CELH stock exhibits above-average volatility.

Investors in the UAE should note that while Celsius offers strong growth prospects and global expansion, its higher valuation and dynamic price swings call for careful consideration.

Our complete analysis on the Celsius Holdings stock

After carefully reviewing Celsius Holdings’ latest financial results and assessing the stock’s performance over the past three years, our quantitative models have synthesized a wide range of data sources—including fundamental metrics, market signals, and peer group analysis—to deliver a comprehensive perspective. The result is a clear identification of structural strengths and accelerating catalysts, despite temporary setbacks. So, why might Celsius Holdings stock once again become a strategic entry point into the fast-growing global non-alcoholic beverage sector in 2025?

Recent Performance and Market Context

Celsius Holdings (NASDAQ: CELH) presently trades at $36.34 per share (as of 30 May 2025), reflecting an intraday increase of +4.04% and a weekly gain of +2.48%. Over the past six months, the stock has surged by +27.73%, signaling shifting momentum following a challenging year that saw a 54.47% decline. This retracement has reset expectations and valuations following the exuberance of 2023 and early-2024, driven by both broader sector rotations and company-specific recalibrations.

Despite a recent dip in reported revenues and earnings, the market has responded positively to key strategic developments. Most notable is the finalized $1.8 billion acquisition of Alani Nutrition (Alani Nu) on 1 April 2025, creating a strong, diversified platform across multiple demographics—particularly targeting growth with female consumers. Furthermore, international revenues showcased robust momentum, rising 41% year-on-year in Q1 2025. This global expansion aligns with elevated investor interest in non-alcoholic, health-oriented beverage trends—an area experiencing accelerated growth not only in the US, but across EMEA and Asia-Pacific.

On a macro level, secular tailwinds remain powerful: increasing consumer prioritization of health, wellness, and functional ingredients are driving up category sales. Regulatory environments in many international markets are also increasingly supportive of “zero sugar” innovations. These tailwinds, combined with Celsius’ sharpened focus and expanded product suite, pave the way for renewed interest in this sector leader.

Technical Analysis

The technical framework for CELH reveals encouraging signals that reinforce the prospect of a new bullish phase. The Relative Strength Index (RSI) presently stands at 50.02—squarely neutral—and offers headroom for further price appreciation without overbought risk. The MACD (Moving Average Convergence Divergence) has turned positive with a current reading of 0.23 since mid-May, suggesting a nascent bullish bias.

• The 50-day moving average ($36.02) has recently crossed above the 200-day ($31.41), forming a “Golden Cross” on 30 April 2025—a classic indicator of a potential long-term uptrend.
• Medium- and longer-term averages (100- and 200-day) both remain notably below current prices, offering robust underlying support.
• The immediate support level is visible at $35.62, with a primary technical floor at $32, while resistance is encountered at $37.25 and $40.

Recent momentum, validated by strong daily volume and positive divergence in the MACD histogram, positions CELH at an inflection point. The alignment of fundamental catalysts with technical confirmation suggests the set-up is highly favorable for entry—particularly for investors seeking medium-term upside from a potential reversal after last year’s correction.

Fundamental Analysis

From a fundamental perspective, Celsius Holdings stands out through a combination of innovation-driven growth, strategic discipline, and high capital efficiency. 2024 full-year revenues climbed to $1.36 billion (+2.85% versus 2023), even as net profit experienced a temporary pullback (-41% YoY) to $107.46 million—primarily reflecting transitory integration and expansion costs.

Earnings per share in Q1 2025 came in at $0.18, marginally below consensus estimates ($0.20). This shortfall should be viewed as an investment phase, rather than a structural weakness, considering the company’s historical track record of delivering profitable expansion.

CELH currently trades at a premium valuation (P/E of 110.1x), yet this is backed by top-tier gross margins, continued reinvestment into R&D, and a scalable asset-light distribution model fueled by its long-term partnership with PepsiCo. Importantly, the acquisition of Alani Nutrition instantly establishes Celsius as the operator of two billion-dollar brands in the United States and diversifies its portfolio to mitigate category risks. The pro forma market share stands at 16.2% in the American energy drink category, trailing only dominant legacy brands such as Monster and Red Bull, and positioning Celsius in a rapidly growing “better-for-you” segment with double-digit annualized growth.

• Strong brand equity and high consumer loyalty, especially within Gen Z and Millennial demographics.
• Continuous innovation in product formulations, leading trends in zero-sugar and functionally enhanced beverages.
• Efficient, diversified global distribution capabilities, now further enhanced by recent M&A synergies.

In sum, while the current valuation requires vigilant monitoring of execution and growth, the structural levers and long-term demand drivers fully justify renewed investor interest at these levels.

Volume and Liquidity

An average daily trading volume of over 8 million shares reflects deep liquidity and consistently robust market interest, providing investors ample flexibility to manage positions. With a public float of 160.34 million shares against a total share count of 257.74 million, CELH’s dynamic valuation is supported by an actively traded base, allowing for price discovery with reduced spreads and limited susceptibility to illiquidity-induced volatility.

Notably, Celsius maintains a sizable cash reserve ($977.3 million) and an exceptionally low debt/equity ratio of 1.55%. This solid financial posture offers critical runway for organic growth, further M&A, and continued investments in innovation, without the need for dilutive capital raises—a key consideration for value-sensitive investors.

Catalysts and Positive Outlook

• Alani Nu Integration: The full realization of revenue and cost synergies, combined product innovation, and expanded addressable market are expected to materialize throughout 2025–2026.
• International Expansion: Outstanding 41% YoY international revenue growth affirms the success of Celsius’ tailored approach in Europe and Asia-Pacific, with substantial runway for further penetration—especially in health-conscious urban markets.
• Category Tailwinds: The non-alcoholic, zero-sugar, and “better-for-you” beverage space continues its double-digit growth, outpacing legacy categories and providing systemic upside beyond the US.
• ESG Leadership: Celsius has demonstrated a proactive stance on product innovation with natural ingredients, ecological packaging, and transparent supply chain sourcing—attributes highly valued by a growing segment of ESG-focused investors.
• Next Earnings Release: The upcoming August results will provide an early indication of post-acquisition synergies and international scale.

These factors, combined with a pipeline of new product launches and platform leverage via global distribution agreements, anchor a positive multi-year outlook for Celsius. The consensus analyst price target of $47.53, representing a premium of nearly 31% to current market levels, attests to this conviction.

Investment Strategies

• Short-Term: Traders may find opportunities around the immediate support at $35.62 and resistance at $37.25, capitalizing on volatility ahead of the next quarterly report. Favorable risk/reward is apparent given the technical consolidation and upward MACD signal.
• Medium-Term: Investors targeting 3–12 month horizons can leverage the Golden Cross signal and positive medium-term momentum, positioning into CELH ahead of expected Alani Nu synergy updates and post-integration earnings beats.
• Long-Term: Allocators with multi-year investment windows appear well-positioned to benefit from the combined compounding effects of international market share gains, category outperformance, and operational scale. The ongoing structural shift toward health-driven consumer products globally further bolsters the case for patient capital.

Optimal entries may be found during any technical pullback toward the $32–$35 range, or in the wake of further consolidation and positive fundamental data, maximizing exposure to upcoming growth catalysts.

Is it the Right Time to Buy Celsius Holdings?

Taking together CELH’s recent strategic acquisitions, surging global presence, robust financial profile, and clearly defined growth levers, the current landscape seems to represent an excellent opportunity for reengagement. While near-term volatility cannot be ruled out given recent earnings noise and a premium valuation, such factors are more than offset by Celsius’ proven resilience, innovation drive, and the massive upside potential embedded in a rapid global shift toward healthier beverage choices.

Supported by technical indicators now turning bullish and liquidity remaining ample, CELH may be entering a new growth phase where the risks are well understood and the reward/risk calculus is attractive—not only for tactical traders but for long-term, growth-focused investors as well.

For those seeking differentiated exposure to the transformational wave in beverage innovation and health-oriented consumption, Celsius Holdings presents a scenario where strong fundamentals, expanded reach, and imminent catalysts all coalesce. As global consumption trends continue their shift and the company executes on its strategic vision, CELH stock stands out as a contender worthy of serious consideration for portfolios looking to capture high-return opportunities in the dynamic consumer health sector.

How to buy Celsius Holdings stock in the UAE?

Buying Celsius Holdings (CELH) stock online is a straightforward and secure process, especially when you use a reputable, regulated broker in the UAE. Today, investors have two accessible choices: purchasing actual shares (spot buying) or trading via Contracts for Difference (CFDs) that track the share price. Both methods allow you to benefit from market movements, but they operate differently. Choosing your ideal option begins with comparing brokers—check out the detailed broker comparison further down this page to help you get started confidently.

Spot buying

A cash purchase, also known as spot buying, means acquiring real Celsius Holdings shares—which you then own directly in your brokerage account. With this method, you pay the current market price plus a fixed brokerage commission, typically ranging from AED 10 to AED 30 per order (or around $2.5 to $8) depending on the UAE broker.

Example

Suppose the Celsius Holdings share price is $36.34 (around AED 133.5), and you invest $1,000 (about AED 3,670), including a brokerage fee of $5. You can buy approximately 27 shares ($1,000 – $5 = $995 / $36.34 ≈ 27 shares).

Gain scenario:
If the share price increases by 10%, your portfolio would now be worth $1,100.

Result: That’s a $100 gross gain, or a +10% return on your investment.

Trading via CFD

CFDs (Contracts for Difference) enable you to speculate on Celsius Holdings’ share price movements without owning the underlying stock. With CFDs, you can use leverage, amplifying both potential gains and risks. CFD trading costs involve the spread (the difference between buy/sell prices) and overnight financing fees for positions held open after market hours.

Example

With $1,000 (about AED 3,670) and 5x leverage, you open a CFD position worth $5,000.

Gain scenario:
If the stock price rises by 8%, your position’s gain becomes 8% × 5 = 40%.

Result: You could potentially earn $400 on your $1,000 stake (exclusive of fees).

Final advice

Before investing, it’s crucial to compare brokers for their commissions, spreads, leverage limits, and overall conditions, as costs can vary significantly. The optimal method—spot buying or CFD trading—depends on your investment objectives: spot buying suits long-term investors seeking ownership, while CFDs are better for active traders or those who want to use leverage. For a tailored choice, make sure to consult the broker comparator provided further down the page. Always invest wisely according to your financial goals and risk profile.

Our 7 tips for buying Celsius Holdings stock

The latest news about Celsius Holdings

Celsius Holdings delivered a strong weekly stock performance, closing up 2.48% with positive intraday momentum. The stock advanced by 4.04% in the last trading session, signaling renewed investor confidence despite recent operational challenges. This rebound was supported by a high average daily trading volume (over 8 million shares) and a favorable market backdrop, particularly in the consumer defensive sector, which is typically seen as resilient in uncertain environments. The firm’s $9.37 billion market capitalization and a consensus price target reflecting over 30% upside reinforce its attractiveness for global investors, including those in the UAE seeking international growth exposure.

The technical outlook for CELH is constructive, highlighted by a bullish Golden Cross and positive MACD signals. Technical indicators remain favorable: on April 30, the 50-day moving average crossed above the 200-day moving average—a classic long-term bullish signal—while the MACD turned positive in May. This momentum is underlined by the current neutral RSI (14-day) at 50.02, and strong supports identified around $32 and $35.62. Such signals are closely watched by quantitative and institutional investors in dynamic financial centers like Abu Dhabi and Dubai, positioning CELH as a technical breakout candidate in the global consumer sector.

The acquisition of Alani Nu for $1.8 billion significantly enhances Celsius Holdings’ portfolio and future growth prospects. Finalized in April 2025, this transaction brings a complementary brand focused on the high-growth female segment of energy drinks, further diversifying Celsius’s product offering and solidifying its competitive advantage in the “better-for-you” beverage category. This strategic move is expected to yield significant synergies and cross-selling opportunities, supporting revenue and profit expansion in North America and internationally—a key consideration for MENA-based funds seeking to tap global health and wellness consumption trends.

International revenue growth accelerated by 41% year-over-year in Q1 2025, highlighting expanding global demand. This sharp rise in non-US revenue underlines successful geographic expansion, especially as Celsius targets emerging markets and growth regions, including a focused push into Asia-Pacific and EMEA. For institutional investors in the UAE, where consumer health trends and demand for international wellness products are rising, this dynamic signals potential for future regional distribution agreements or product launches, bolstered by the company's robust partnership network and innovation pipeline.

Analyst sentiment remains moderately optimistic, with a consensus “Buy” and 20% projected sales growth for 2025. Seventeen covering analysts have reinforced a positive outlook, citing strong brand equity, ongoing international scaling, and the integration of the Alani Nu acquisition as primary catalysts. The stock’s high price-to-earnings ratio reflects growth expectations but is supported by a low debt-equity profile and substantial cash reserves ($977 million), offering reassurance to institutional allocators and sovereign wealth funds in the UAE when seeking stable, innovation-led investments in global equities.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.